Ventricular Lead Dislodgement Detection During Atrial Fibrillation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Implantable medical devices face challenges in reliably detecting ventricular lead dislodgement during atrial fibrillation, which can lead to inappropriate sensing of cardiac signals and delivery of therapy, potentially causing unnecessary or inappropriate shock therapy.
Innovation Solution
The system includes sensing circuitry and processing circuitry in an implantable medical device to detect characteristics such as reduced amplitude and increased variability of RR intervals in cardiac signals, allowing for the detection of ventricular lead dislodgement during atrial fibrillation and providing a lead dislodgement alert to prevent inappropriate therapy delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If the implantable medical device uses standard sensing methods to detect cardiac signals, then the device can monitor cardiac rhythm, but it cannot reliably distinguish between atrial and ventricular signals during atrial fibrillation, leading to potential lead dislodgement misdiagnosis
Solution Approach 1:
The patent segments the detection process into multiple independent analysis components: atrial signal detection, ventricular signal detection, RR interval analysis, and signal morphology analysis. Each component evaluates specific characteristics and combines results to improve overall detection accuracy during atrial fibrillation
Solution Approach 2:
The patent adds temporal dimension analysis by examining RR interval variability and signal characteristics over time. This multi-dimensional approach (amplitude, timing, morphology, variability) enables reliable distinction between atrial and ventricular signals that single-parameter methods cannot differentiate
2Productivity
If the device delivers therapy based on standard ventricular fibrillation detection algorithms, then it can respond to detected arrhythmias, but it may deliver inappropriate shock therapy when the ventricular lead is dislodged during atrial fibrillation
Solution Approach 1:
The patent applies preliminary anti-action by implementing pre-therapy verification checks that actively prevent inappropriate therapy delivery. The system checks signal morphology, RR interval consistency, and chamber-specific characteristics before authorizing shock therapy, thereby counteracting potential false positive detections
Solution Approach 2:
The patent implements feedback mechanisms where the detected signal characteristics continuously inform therapy delivery decisions. The system uses real-time analysis of atrial versus ventricular signal patterns to confirm or reject arrhythmia detection, creating a feedback loop that prevents inappropriate therapy while maintaining rapid response to true events
3Reliability
If the device monitors cardiac signals continuously to detect lead dislodgement, then it can identify dislodgement events, but it increases complexity of signal analysis and processing requirements
Solution Approach 1:
The patent applies preliminary action by establishing baseline signal characteristics during normal sinus rhythm before atrial fibrillation occurs. These pre-established templates are stored and used for comparison during AF episodes, eliminating the need for complex real-time learning algorithms while maintaining high detection accuracy
Solution Approach 2:
The patent changes detection parameters dynamically based on the detected cardiac rhythm state. During sinus rhythm, the system uses one set of detection parameters, while during atrial fibrillation, it switches to AF-optimized parameters including different RR interval thresholds and signal morphology criteria, simplifying processing for each specific condition
Data Source
AI summary
A medical device system and method for detecting dislodgement of a lead determines one or more characteristics of a cardiac signal received via the lead that are associated with dislodgement of the lead during atrial fibrillation, and detects dislodgement of the ventricular lead based on the determined characteristics. The medical device and system provides a lead dislodgment alert in response to detecting dislodgement. In some examples, an implantable medical device withholds delivery of a defibrillation therapy based on detecting dislodgement of the lead.